US FDA accepts supplemental Biologics License Application for Merck’s Enflonsia
The treatment is to protect children under two years of age from respiratory syncytial virus
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
Pfizer announces phase 3 results for nonsegmental vitiligo treatment
Litfulo delivered significant, clinically meaningful improvements for both face and body
Lilly to acquire AtaiBeckley in deal worth $2.8bn
The acquisition will advance therapies for treatment-resistant depression and other mental health conditions
US FDA accepts supplemental Biologics License Application for Merck’s Enflonsia
The treatment is to protect children under two years of age from respiratory syncytial virus
Number of women in England receiving HRT on the NHS more than doubles
A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21
Johnson & Johnson announces change in senior leadership role
Tom Cavanaugh has been appointed as Executive Vice President, Worldwide Chairman Innovative Medicine
Latest content
Saatchi & Saatchi Health London appoint Pedro Rosa and May Leen Wong
Rosa was previously at VML UK and Wong was at Havas Health
Read More
The AI concierge: how biopharma is evolving HCP service
As biopharmas move towards Agentic Commercial, service evolution is key to delivering the frictionless, 24/7 experience HCPs demand
Read More
Navigating patient experience data in rare disease
Meaningful engagement is not defined solely by trial outcomes, but by whether patients feel heard, informed and involved throughout the development process
Read More
Patient-centred healthcare communications: why co-creation drives better creative ideas
When people recognise their own experiences in communications, trust grows
Read More
Intelligence
Forging a connection through creativity
A spark of creativity can cut through complexity, adding real value and helping to forge true connections with patients
Read More
The UK’s life sciences’ crossroads: competing in a market defined by speed, scale and investment
The UK’s challenge is less about capability and more about how well it aligns with the way global pharma now operates
Read More
Launching into an AI-powered future: a prescription for success
Making launch more effective, precise, cost-effective and agile demands new thinking and new technologies
Read More
ASCO 2026: the art of translation
Translating emerging science into care that works meaningfully in practice
Read More
Steering generative AI into the pharma fast lane
Industry needs to press the accelerator to adopt AI across functions to
supercharge launch excellence
Bridging the gap between European brain innovation and real-world policy
Aligning policy and public funding strategies to support brain health across Europe
Read More
Blogs
Latest
Why Modern Dermatology Demands Curiosity Over Precision
August 5, 2026 | Medscape Education|
In the high-stakes world of healthcare research and product development, success has long been measured by rigid definitions of precision and predictable trajectories. However, as …
Moving Beyond the Pill: Unlocking Value Through Engaged, Empowered, and Educated Patients
July 30, 2026 | Impetus Digital|Health Outcomes, Impetus Digital, Market Access, Medical Innovation, PSP, Pharma Strategy, Value-based care, beyond the pill, digital health, digital voice, health innovation, health literacy, patient activation, patient engagement, patient support program, patientcentricity, real world data, treatment adherence
True “beyond-the-pill” strategy requires shifting from a prescriptive model to a supportive one—using personalized digital tools and authentic patient voices to drive adherence, improve outcomes, …
The Heart of the Matter: Medscape Education’s Cardiology Footprint at ESC 2026
July 28, 2026 | Medscape Education|CME, Cardiology Education, IME, Patient Impact, cardiology
For more than 30 years, Medscape Education has built independent, accredited cardiovascular education designed around one goal: improved patient outcomes. This year at the European …
What do patient stories actually teach us?
July 21, 2026 | Mednet|Making Health Whole, Patient Stories, health communications, marketing strategy, medcomms
How do we translate individual experiences into support that helps others and create support that feels personal but remains relevant to many?
More Than Pink Walls: What Women-Centric Care Actually Requires
July 15, 2026 | Medscape Education|
The phrase “patient-centered care” is tossed around freely in healthcare corporate boardrooms. Yet, for more than half the population, that promise routinely fractures. In the …
Permission to pause: making treatment breaks part of the cancer care conversation
August 5, 2026 | Cuttsy + Cuttsy|Cancer, Social Listening, Treatment breaks, Treatment pause, oncology
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.
A seat at the table: what the EU HTA reforms really ask of patient involvement
July 24, 2026 | Cuttsy + Cuttsy|EU HTA, Patient involvement, clinical trials, design
The EU HTA reforms give patients a formal role in assessing new medicines, but meaningful involvement requires more than simply offering them a seat at …
Infographic: Are data blind spots putting your launch at risk?
July 16, 2026 | Inizio|AI, Pharma, Product Launch, healthcare
Commercial pharma launches depend on confident, evidence-led decisions. Yet many launch teams are still working with fragmented data spread across multiple systems, making it difficult …
Why faster trials make participant understanding more important than ever
July 15, 2026 | Cuttsy + Cuttsy|Informed Consent, clinical trials, communication
As clinical trials accelerate, clear, accessible consent is essential to help participants understand, engage with and remain in a study.